Vaccines Webinar | Infection and (Presymptomatic) Transmission of SARS-CoV-2
Webinar Information
1st Vaccines Webinar
Infection and (Presymptomatic) Transmission of SARS-CoV-2
SARS-CoV-2 is the newly identified human coronavirus that emerged in December 2019, resulting in severe respiratory disease and viral pneumonia. The disease was later named COVID-19 and has resulted in thousands of deaths to date. Research is underway to understand the transmission and pathogenicity, and to develop treatments and preventative measures for this serious illness. This webinar will discuss the latest advances in understanding the spread of SARS-CoV-2 and its pathogenicity, and will highlight the progress in vaccine and antiviral drug development.
Date: 4 December 2020
Time: 2pm (CET) | 8am (EDT) | 9pm (CST Asia)
Webinar ID: 868 8022 2663
Chair: Dr. Hatem Elshabrawy
Webinar Secretariat: vaccines.webinar@mdpi.com
This webinar will include the following experts:
|
Dr. Hatem Elshabrawy |
Affiliation: Assistant Professor at Sam Houston State University, College of Osteopathic Medicine Interests: Development of antiviral small molecules and antibodies
|
|
Dr. Francesco De Sanctis |
Affiliation: Università degli Studi di Verona, Sez.Immunologia, Dipartimento di Medicina, Policlinico G.B. Rossi, Italy Interests: immunology; cancer immunology; cancer immunotherapy; tumor microenvironment; TILs; adoptive cell therapy; T cells; tumor immunosuppression; MDSCs; tumor vaccination |
|
Prof. Maria Anagnostouli |
Affiliation: Neurology Demyelinating Diseases Unit & Director of Immunogenetics Laboratory, 1st Department of Neurology of the Medical School, National and Kapodistrian University of Athens, Athens, Greece Interests: clinical immunology; immunogenetics; neurology; multiple sclerosis; demyelinating diseases; autoimmunity |
|
Dr. Hussin Rothan |
Affiliation: Department of Biology, College of Arts and Sciences, Georgia State University, Atlanta, GA 30302 USA Interests: flavivirus; alphaviris; vaccines; nanoparticles; antibody responses |
|
Dr. Kathleen L. Hefferon |
Affiliation: Department of Cell and Systems Biology, University of Toronto, St. George Campus, 25 Willcocks Street, Toronto, ON M5S3B2, Canada Interests: vaccines; plant viruses; virus expression vectors; tobacco mosaic virus; potato virus X; cowpea mosaic virus; nanoparticles |
Program
The webinar will start at 2:00 pm (CET) and will last maximum 2 hours.
|
Presentation |
Time CET |
Time EDT |
Time CST |
|
Dr. Hatem Elshabrawy Introduction |
2:00pm |
8:00am |
9:00pm |
|
Dr. Francesco De Sanctis "Deciphering the state of immune silence in fatal COVID-19 patients" |
2:05pm |
8:05am |
9:05pm |
|
Q&A |
2:25pm |
8.25am |
9:25pm |
|
Prof. Maria Anagnostouli "Host HLA-genotype and COVID-19 infection. Impact on severity, clinical outcome and therapeutics " |
2:30pm |
8:30am |
9:30pm |
|
Q&A |
2:50pm |
8:50am |
9:50pm |
|
Dr. Hussin Rothan: "The widespread of SARS-CoV-2 virus could be attributed to the genetic variation in the viral spikes " |
2:55pm |
8:55am |
9:55pm |
|
Q&A |
3:15pm |
9:15am |
10:15pm |
|
Dr. Kathleen L. Hefferon: "Using Plants to Fight COVID-19" |
3:20pm |
9:20am |
10:20pm |
|
Q&A |
3:40pm |
9:40am |
10:40pm |
|
Concluding remarks |
3:45pm |
9:45am |
10:45pm |
Webinar Content
The first Vaccines webinar was organised on 4 December 2020. The online seminar was chaired by Dr. Hatem Elshabrawy, Assistant Professor at Sam Houston State University.
The first presentation was given by Dr. Francesco De Sanctis, from University of Verona. He talked about deciphering the state of immune silence in fatal COVID-19 patients. He was followed by Prof. Dr. Maria Anagnostouli, from National and Kapodistrian University of Athens. Her talk was on the Host HLA-genotype and COVID-10 infection and its impact on severity, clinical outcome and therapeutics.
Dr. Hussin Rothan from Georgia State University was the third presenter and discussed how the widespread of SARS-CoV-2 virus could be attributed to the genetic variation in the viral spikes. The fourth and final presentation was given by Dr. Kathleen Hefferon from University of Toronto. She presented a different approach – that of using plants to fight COVID-19.
Each presentation was followed by a short Q&A, where the presenters answered the questions from the attendees. The webinar was offered via Zoom and required registration to attend. The full recording can be found below. In order to stay updated on the next webinars on Vaccines, be sure to sign up for our newsletter by clicking on “Subscribe” at the top of the page.
Relevant Special Issue
Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19
Guest Editor: Dr. Hatem A. Elshabrawy
Deadline for manuscript submissions:31 December 2020
Sponsors and Partners
Organizers
